ELIQUIS (apixaban)

15:47 EST 24th November 2017 | BioPortfolio

ELIQUIS (apixaban) is an oral direct Factor Xa inhibitor.

Eliquis is an oral drug used for preventing blood clots in patients with atrial fibrillation. It is an anticoagulant that works by blocking the action of factor Xa. Factor Xa is an important protein in the coagulation cascade that causes blood to clot. Reducing the action of factor Xa reduces the ability of blood to clot. In patients with atrial fibrillation there is increased risk of blood clots which can travel to the brain where it causes strokes as well as to other organs.

Quick Search

review and buy ELIQUIS (apixaban) market research data and corporate reports here